Brevetti EPO No.2834239 2017.12.27
Brevetti EPO
(10) Registration Number and Date
2018000142 2018.03.16
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2018/000142 2013.04.02
(40) Publication Number and Date
SM /T/2018/000142 2018.03.16
(30) Priority Details
US 201261618993 P
2012.04.02
(71/73) Applicant
(72) Inventor
(IT) BIST, Shanta : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) DUSSAULT, Daemian : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) WU, Ye : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) ZHAO, Liang : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) MCGUIRE, Helen : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) CHEN, Brendan : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) GENG, Bolin : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) HUYNH, Hoan : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(IT) XIONG, Hui : AstraZeneca R&D Boston35 Gatehouse Drive, Waltham, Massachusetts 02451, US
(74) Representative Name
(IT) INCHINGALO, Simona : Via O. Scavino, 10, 47891 Rovereta RSM, SM
(54) Title
(IT) COMPOSTI ETEROBICICLICI COME INIBITORI DI BETA-LATTAMASI
(EN) HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS
(57) Abstract
(58) Citations